NUVALENT INC
NUVL·670703107·US·equity·Healthcare - Biotechnology-13D/G
NUVL (NUVALENT INC) is held by 140 institutional investors as of Q1 2026. Largest holders: FMR LLC ($950.2M), BlackRock, Inc. ($494.3M), JPMORGAN CHASE & CO ($298.7M). Net institutional sentiment: Mixed.
140
Holders
Avg rating(11 Elite)
$4.2B
Total Value
64% (149)
Fund Consensus
89 buying - 51 selling
Smart Money Verdict42Weak MomentumSplit Signals
Get 5 free verdicts/month - sign up in 10 seconds
See how NUVL's score breaks down across 4 SEC sources
Held by 140 funds
11 elite
Who's Trading
13F: Insider & Congress:
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Decreased | 9.3M(-14.5%) | $950.2M | 0.1% | +28.65% | 0 | |
Increased | 4.8M(+0.4%) | $494.3M | 0.0% | +25.54% | 31 | |
Increased | 3.1M(+40.0%) | $298.7M | 0.0% | +13.89% | 41 | |
Increased | 2.5M(+34.8%) | $259.6M | 2.8% | +10.36% | 68 | |
Increased | 2.5M(+0.3%) | $253.1M | 0.0% | +40.39% | 31 | |
Increased | 2M(+9.2%) | $208.6M | 0.0% | +26.63% | 33 | |
Increased | 1.8M(+19.2%) | $187.6M | 0.7% | +14.88% | 51 | |
Increased | 1.3M(+4.8%) | $133M | 0.0% | +69.85% | 32 | |
Decreased | 1.2M(-17.5%) | $126.8M | 0.1% | +33.65% | 0 | |
Decreased | 784,023(-0.2%) | $78.9M | 0.0% | +4.46% | 0 | |
Increased | 748,896(+16.5%) | $76.7M | 0.1% | +16.07% | 41 | |
Unchanged | 610,459 | $62.5M | 0.2% | +26.08% | 0 | |
Decreased | 563,768(-0.1%) | $57.8M | 0.0% | +23.78% | 0 | |
Decreased | 537,158(-9.6%) | $55M | 0.0% | +23.73% | 0 | |
Decreased | 481,180(-0.5%) | $49.3M | 0.4% | +41.57% | 0 | |
Increased | 479,998(+1.0%) | $49.2M | 0.5% | +1.91% | 35 | |
Decreased | 450,801(-0.6%) | $46.2M | 0.0% | +54.39% | 0 | |
Increased | 434,742(+5.7%) | $44.5M | 0.0% | +24.00% | 31 | |
Increased | 431,067(+15.2%) | $44.2M | 0.0% | +26.69% | 33 | |
Increased | 429,373(+4.6%) | $44M | 0.0% | +80.54% | 31 |
